BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18181327)

  • 21. Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma?
    Song GW; Lee SG; Hwang S; Kim KH; Cho YP; Ahn CS; Moon DB; Ha TY
    Hepatogastroenterology; 2009; 56(93):935-42. PubMed ID: 19760915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent of liver resection for hilar cholangiocarcinoma.
    Chen XP; Lau WY; Huang ZY; Zhang ZW; Chen YF; Zhang WG; Qiu FZ
    Br J Surg; 2009 Oct; 96(10):1167-75. PubMed ID: 19705374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic portal tumor--today].
    Wagner HE; Ballmer FT; Blumgart LH
    Schweiz Med Wochenschr; 1987 Dec; 117(52):2104-12. PubMed ID: 2829350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hilar cholangiocarcinoma: thin-section spiral CT findings with cholangiographic correlation.
    Han JK; Choi BI; Kim TK; Kim SW; Han MC; Yeon KM
    Radiographics; 1997; 17(6):1475-85. PubMed ID: 9397459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
    Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
    J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases.
    Zhang HY; Kong YL; Zhang HY; He XJ; Zhang H; Liu CL; Zhao G; Xiao M; Zhang XD; Feng ZQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):418-21. PubMed ID: 18693179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiolocellular carcinoma of the liver: CT and MR findings.
    Fukukura Y; Hamanoue M; Fujiyoshi F; Sasaki M; Haruta K; Inoue H; Aiko T; Nakajo M
    J Comput Assist Tomogr; 2000; 24(5):809-12. PubMed ID: 11045707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings.
    Kim TK; Choi BI; Han JK; Jang HJ; Cho SG; Han MC
    Radiology; 1997 Aug; 204(2):539-43. PubMed ID: 9240550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
    Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
    J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concept of perihilar cholangiocarcinoma is valid.
    Ebata T; Kamiya J; Nishio H; Nagasaka T; Nimura Y; Nagino M
    Br J Surg; 2009 Aug; 96(8):926-34. PubMed ID: 19591162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Ormond's disease associated with bile duct stricture mimicking cholangiocarcinoma.
    Quante M; Appenrodt B; Randerath S; Wolff M; Fischer HP; Sauerbruch T
    Scand J Gastroenterol; 2009; 44(1):116-20. PubMed ID: 18759151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis of curative resection with hemihepatectomy for advanced hilar cholangiocarcinoma].
    Sun Y; Wu ZY; Hao CY; Huang XF; Wang K; Bao Q; Qian HG; Xing BC
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):527-30. PubMed ID: 18649767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
    Kim JH; Yoon HK; Sung KB; Ko GY; Gwon DI; Shin JH; Song HY
    Cancer; 2008 Oct; 113(7):1614-22. PubMed ID: 18704990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic hilar resection for hilar cholangiocarcinoma based on a reclassification.
    Cho A; Asano T; Yamamoto H; Nagata M; Takiguchi N; Kainuma O; Souda H; Gunji H; Miyazaki A; Nojima H; Ikeda A; Matsumoto I; Ryu M; Koike N
    Hepatogastroenterology; 2008; 55(86-87):1764-6. PubMed ID: 19102387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge.
    Zhou X; Wang J; Tang M; Huang M; Xu L; Peng Z; Li ZP; Feng ST
    BMC Cancer; 2020 Jan; 20(1):54. PubMed ID: 31969123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.
    Lee HY; Kim SH; Lee JM; Kim SW; Jang JY; Han JK; Choi BI
    Radiology; 2006 Apr; 239(1):113-21. PubMed ID: 16467211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes.
    Kim NR; Lee JM; Kim SH; An SK; Han CJ; Choi SH; Han JK; Lee HS; Jang JJ; Choi BI
    Clin Imaging; 2008; 32(2):114-20. PubMed ID: 18313575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
    Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
    Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic perfusion disorders: Computer-tomographic and magnetic resonance imaging.
    Lupescu IG; Grasu M; Capsa R; Pitrop A; Georgescu SA
    J Gastrointestin Liver Dis; 2006 Sep; 15(3):273-9. PubMed ID: 17013453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.